Evidence map›Paper›PMID 35532916›Full record

SynthesisCanadian journal of psychiatry. Revue canadienne de psychiatrie2022

SARS-CoV-2 Infection and the Risk of Suicidal and Self-Harm Thoughts and Behaviour: A Systematic Review.

Mark Sinyor, Rabia Zaheer, Roger T Webb, Duleeka Knipe, Emily Eyles, Julian P T Higgins, Luke McGuinness, Lena Schmidt, Catherine Macleod-Hall, Dana Dekel and 2 more

Open access · hybridAbstract readSystematic Review
In one paragraph

Synthesis in Canadian journal of psychiatry. Revue canadienne de psychiatrie, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 3 countries.

Mark SinyorDepartment of Psychiatry, Sunnybrook Health Sciences Centre, Toronto, Canada.ORCID 0000-0002-7756-2584
Rabia ZaheerDepartment of Psychiatry, Sunnybrook Health Sciences Centre, Toronto, Canada.
Roger T WebbDivision of Psychology and Mental Health, University of Manchester, Manchester, UK.
Duleeka KnipePopulation Health Sciences, Bristol Medical School, 1980University of Bristol, Bristol, UK.
Emily EylesPopulation Health Sciences, Bristol Medical School, 1980University of Bristol, Bristol, UK.
Julian P T HigginsPopulation Health Sciences, Bristol Medical School, 1980University of Bristol, Bristol, UK.
Luke McGuinnessPopulation Health Sciences, Bristol Medical School, 1980University of Bristol, Bristol, UK.
Lena SchmidtPopulation Health Sciences, Bristol Medical School, 1980University of Bristol, Bristol, UK.
Catherine Macleod-HallPopulation Health Sciences, Bristol Medical School, 1980University of Bristol, Bristol, UK.ORCID 0000-0002-0487-0674
Dana DekelPopulation Data Science, 7759Swansea University, Swansea, UK.
David GunnellPopulation Health Sciences, Bristol Medical School, 1980University of Bristol, Bristol, UK.
Ann JohnPopulation Data Science, 7759Swansea University, Swansea, UK.
University Hospitals Bristol NHS Foundation Trust · GBUniversity of Bristol · GBSunnybrook Health Science Centre · CASwansea University · GBResearch Triangle Park Foundation · USUniversity of Manchester · GB

Funding

Medical Research Council MR/K006525/1Wellcome Trust 204813
6 · The paper itself

Abstract

objectiveThe COVID-19 pandemic has had a complex impact on risks of suicide and non-fatal self-harm worldwide with some evidence of increased risk in specific populations including women, young people, and people from ethnic minority backgrounds. This review aims to systematically address whether SARS-CoV-2 infection and/or COVID-19 disease confer elevated risk directly.

methodAs part of a larger Living Systematic Review examining self-harm and suicide during the pandemic, automated daily searches using a broad list of keywords were performed on a comprehensive set of databases with data from relevant articles published between January 1, 2020 and July 18, 2021. Eligibility criteria for our present review included studies investigating suicide and/or self-harm in people infected with SARS-CoV-2 with or without manifestations of COVID-19 disease with a comparator group who did not have infection or disease. Suicidal and self-harm thoughts and behaviour (STBs) were outcomes of interest. Studies were excluded if they reported data for people who only had potential infection/disease without a confirmed exposure, clinical/molecular diagnosis or self-report of a positive SARS-CoV-2 test result. Studies of news reports, treatment studies, and ecological studies examining rates of both SARS-CoV-2 infections and suicide/self-harm rates across a region were also excluded.

resultsWe identified 12 studies examining STBs in nine distinct samples of people with SARS-CoV-2. These studies, which investigated STBs in the general population and in subpopulations, including healthcare workers, generally found positive associations between SARS-CoV-2 infection and/or COVID-19 disease and subsequent suicidal/self-harm thoughts and suicidal/self-harm behaviour.

conclusionsThis review identified some evidence that infection with SARS-CoV-2 and/or COVID-19 disease may be associated with increased risks for suicidal and self-harm thoughts and behaviours but a causal link cannot be inferred. Further research with longer follow-up periods is required to confirm these findings and to establish whether these associations are causal.

Indexed as

COVID-19Self-Injurious BehaviorAdolescentEthnicityFemaleHumansMinority GroupsPandemicsSARS-CoV-2Suicidal IdeationCOVID-19SARS-CoV-2self-harmsuicidesystematic review

Identifiers

PMID35532916
PMCPMC9096003
OpenAlexW4229454413

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.